U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Entia Biosciences, Inc (ERGO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0130.000 (0.000%)
At close: 9:30AM EDT
People also watch
HMGNKDUSAVXTEMISCYAN
Full screen
Previous Close0.013
Open0.000
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.000 - 0.000
52 Week Range
Volume0
Avg. Volume6,173
Market Cap437.59k
Beta0.81
PE Ratio (TTM)-0.26
EPS (TTM)-0.05
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Entia Biosciences, Inc. :ERGO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016
    Capital Cube10 months ago

    Entia Biosciences, Inc. :ERGO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016

    Categories: Yahoo Finance Get free summary analysis Entia Biosciences, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Entia Biosciences, Inc. – Hudson Global, Inc., Kforce Inc., TeleTech Holdings, Inc., ManpowerGroup Inc. and Insperity, Inc. (HSON-US, KFRC-US, TTEC-US, MAN-US and NSP-US) that have also reported for ... Read more (Read more...)

  • We're sorry this is all we were able to find about this topic.